Relay Therapeutics (RLAY)
(Delayed Data from NSDQ)
$4.66 USD
+0.11 (2.42%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $4.67 +0.01 (0.21%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth B Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Relay Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
RLAY 4.66 +0.11(2.42%)
Will RLAY be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for RLAY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RLAY
Investing in Oncology: 3 Cancer Stocks With Promising Pipelines
Relay Therapeutics (RLAY) Upgraded to Buy: What Does It Mean for the Stock?
RLAY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Relay Therapeutics, Inc. (RLAY) Reports Q2 Loss, Beats Revenue Estimates
RXRX vs. RLAY: Which Precision Biotech Stock is a Better Bet Now?
Can Recent Pipeline Expansion Efforts Offset RXRX's Earlier Losses?
Other News for RLAY
Is RLAY gaining bullish strength? Expansion Breakout shows up after rallying 11.25%
RLAY's price falls by 0.97% on September 17, though its technical setup remains stable.
Is RLAY poised for gains? New Uptrend shows up after climbing 1.72%
RLAY forms Pocket Pivot on September 15
RLAY forms Golden Cross on September 12